Showing results (1-10 of 218) with videos related to
Sort By:
Pageof 22
Atherosclerosis|July 1, 1996
Triglycerides: a risk factor for coronary heart diseaseJ Davignon, J S CohnArteriosclerosis, Thrombosis, and Vascular Biology|October 16, 1999
Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteinsJ S Cohn, C Marcoux, J DavignonJournal of Lipid Research|January 1, 1997
Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpEL Krimbou, M Tremblay, J Davignon, et al.Journal of Lipid Research|November 30, 1998
Association of apolipoprotein E with alpha2-macroglobulin in human plasmaL Krimbou, M Tremblay, J Davignon, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|October 8, 1999
Apolipoprotein E and atherosclerosis: insight from animal and human studiesJ Davignon, J S Cohn, L Mabile, et al.Biochimica Et Biophysica Acta|June 23, 1997
Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjectsC Marcoux, S Lussier-Cacan, J Davignon, et al.Atherosclerosis|July 11, 1997
Pseudo type III dyslipoproteinemia is associated with normal fibroblast lipoprotein receptor activityL M Giroux, J S Cohn, J LaMarre, et al.Metabolism: Clinical and Experimental|February 15, 2001
Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteinsC Marcoux, M Tremblay, A Fredenrich, et al.Journal of Lipid Research|April 29, 1998
In vitro factors affecting the concentration of gamma-LpE (gamma-LpE) in human plasmaL Krimbou, M Tremblay, H Jacques, et al.Journal of Lipid Research|April 7, 1999
Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patientsC Marcoux, M Tremblay, K Nakajima, et al.Pageof 22